



































































































































































































































































































































































































































































o 1 3 6 TIME (Hours)-24
Fig. 5.Concentration of i4C-tripalmitin in the right iliac lymph node
after intramuscular injection of various oil formulations.
D, Oily solution; O, O/w emulsion; A, W/O ernulsion; e, S/O












28 o l 3 6 TIME (Hours)Vr'-     24
Fig. 6.Concentration of i4C-tripalmitin in the left iliac lymph node
after intramuscular injection of various oil formulations. [],
Oily solution;O, O/VV emulsion; ZN, W/O emulsion; e, S/O















o 1 3 6 TIME (Hours)    24
Fig. 7.Concentration of i4C-trip'almitin.in the blood after intramuscular
injection of various oil formulations, [],Oily s'olution; O, O/W
emulsion; zCS,'W70 emulsion; e, SIO emulsion. Results are









          t tt                 TIME CHours) '
The ratio of the concentratlon of i4c-tripalmitin in the right
iliac lymph node to the }eft iliac lymph node (R/L ratio)
after intramuscular injection of various oil formulations. [],







































































































o 15 30 60 180
TIME (MinutEsD
Fig. 11. Concentration of hippuran in the right 'iilliac .lymph node after
     intravenous injection or intramuscular iaj.ectian ･of various
  ' formulations. O. Intravenous injectiQn; [], in' tr-amuscular
     injection of aqueous solution; A. intrammsotilar iajection of
     WIO emu}sion; e, intramuscular injeediQE! of SX(I) emulsion.














o 15 30 60
TIME (Minutes.)
180
Concentration of hippuran in the left l}iac i.ymqh node after
intravenous injection or intramuscular .injegction of various
formulations. O, Intravenous injection; [], iritrarnuscular
injection of aqueous solution; A, intramusctilar injection of
WIO emulsion: e, intramuscular injection of S/O emulsion.































































































ンを胃壁に注射 し全身的な油脂の移行を精査 した｡ Flg.17には,S/0型エマルション注射後の血液中お
よび胸管リンパ中濃度を所属 リンパ節中濃度とともに示 したo血液はラットの頚動脈にカニュレーション












05 30 60 180TIME (Minutes)
Fig.15. Disappearance of i4C-tripalmitin from the stomach wall .a[Eter
    injection of various oil formulations. [], Oily solution; z<X,
    VL70 emulsion; e, S/O emulsion. Results are expressed as






zavzo20Hh< ecF z ut v z olOo
05 so 60 TIME (Minutes)180
Fig. 16. Concentration of i4C-tripalmitin in the regional lymph node
        after intragastric injection of various oil formulations. [],
        Oily solution; ,(X, WIO emulsion; e, S/O emulsion. Rcsults











































































































注射 した場合のリンパ節-の分布は常に′トさく,これに対 し,水溶液の形で注射 した場合は注射直後に有
意に高いリンパ節中濃度が示され, hlppuranが注射部位から所属 リンパ節へ移行することが示唆された｡ し
かしこの直接移行は注射後 15分以内に終了することも明らかとなった｡S/0型エマルションは最も高い濃




































































































































































































































      05 15. 30 60                           TIME .(Minutes)
. 23. Disappearance of radioactive 5-FU from the thigh muscle
     after injection of various formulations. [], Aqueous solution;
     A, VLIfO emulsion; e, S/O emulsion. Results are expressed
     as the mean±SE of at least five animals.








        O 15 30 45 60 90 l20
                    TIME (Minutes)
Plasma concentration of 5-FU after intravenous injection
or intramuscular injection of various formulations. O,
Intravenous injection; [], intramuscular injection of aqueous
solution; A, intramuscular injection of VL70 emulsion; e,
intramuscular injection of S/O emulsion. Results are











O l5 3060 180TIME (Minutes)
Fig. 25. Concentration of radioactive 5-FU in the right iliac lymph
     node after intravenous injection or intramuscular injection
     of various formulations. O, Intravenous injection; [I], intra-
     muscular injection of aqueous solution; A, intramuscular
     injection of VgeXO emulsion; e, intramuscular injection of
     S/O emulsion. Results are expressed as the mean±SE of







O 15 3060 TIME <Minutes)180
Fig.26. Concentration of radioactive 5-FU in the left iliac lymph
    node after intravenous injection or intramuscular injection
     of various formulations. O, Intravenous ipjection; D, intra-
     muscular injection of aqueous solution; A, intramuscular
     injection of VSLfO emulsion;e, intramuscular injection of
     S/O emulsion.Results are expressed as the mean±SE of












































































                         TIME (Minutes)
Concentration of radioactive 5-FU in the regional lymph
node after intravenous injection or intragastric injection
of various formulations. O, Intravenous injection; [],intra-
 'gastric injection of aqueous solution; A, intragastric injec-
tion of VgVO emulsion; e, intragastric injection of S/O '
emulsion. Results are expressed as the mean±SE of at
least five animals.















O 30 60 030 60 90      TIME,(Minutes) TIME (Minutes)
Concentration of 5-FU in the thoracic lymph (a) and
average lymph flow (b) after intravenous injection or
intragastric injection of various formulations. O, Intra-
venous injection; D, intragastric injection of aqueous
solution; Lx, intragastric injection of ywO emulsion; e,
intragastric injection of S/O emulsion. Results are











































































































































































































































































































































































































o   6 12 24




            48 TIME (Hdurs) ･
             '
    tt            't ti4C-tripalmitin from the
various injection volume
, 20 ptl; D, 50 ptl. Results
of five animais.












o lo 2e 3o 4o so             INJECTIoN VoLuME (Microliter) .
                  '                         '' '                'Effect of iniection volume on the disappearance of
i4C-tripalmitin from the thigh muscle aftre injection
of various oil formulations. [], oily solution; tc>ts, W/O
g,M",ggi O."8.e. Gi,(]' .2m.", 'f.'s,e P, s2"k s, ,fize,,gxpressed














































































































































































































































































































































































































































    o O.5-1 ' 2･' ･ 3''''24.'72                 .. 1. .. TIME (Hours) -/i,' , ..
47. Concentration of bleorbY6in in the regional IY'mph node after
  , injection with various conditions. O, Intravenons injection
   of aqueous solution; [],topical injection of aqueous solution;
   e, topical injection of S/O emulsion. Results are expressed
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                          TIME (Hours) ' ･ ' '
Plasma concentration of bleomycin after injection with
various injection conditions. O, Intravenous injection of
aqueous solution; O, topical injection of aqueous solution;
e, topical injection of S/O emulsion. Results are expressed
























































































Table12. Bleomycin Concentrations at
   Injection with SIO Emulsion
   Bearing Rabbit.





Cbncentration (#glinl or g)












Photographs of the primary tumor and the metastasized
lymph node at immediately after injection of SIO
emulsion into the appendix wall near the primary tumor.
SIO emulsion (stained with sudan blue) intruded into
the lymph vessels and drained into the lymph node.
S'rFt/ '" N; "'W" a.'" .z"lets:･ tw..
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pheral lymph fluid drained
from the appendix which
had an injection of SIO
emulsion at the sub-serosal
layer. Lipophilic dye ( sudan
blue )was dissolved in the



























































Fig. 53.Photographs of the stomach
regional lymph node of the
immediately after injection
 wal1 and the
dog at
of SIO emulsion.
Fig. 54.Photographs of the
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